Full-Time
Vice President
Clinical Development, Early Oncology Development
Posted on 5/6/2024
Develops targeted small-molecule cancer drugs
Senior
San Francisco, CA, USA
At Scorpion Therapeutics, our pursuit of advancing Precision Oncology 2.0, by developing targeted small-molecule drugs, makes us a leading edge in the field. With a focus on pioneering advancements in target discovery and medicinal chemistry, we are committed to overcoming the limitations of current cancer therapies. This creates a dynamic working environment, where employees are engaged in meaningful work that has the potential to significantly enhance patient outcomes in oncology.
Company Stage
Series A
Total Funding
$132.7M
Headquarters
Boston, Massachusetts
Founded
2020